Molecular Basis of Apoptosis Induced by Taraxasterol on Human Melanoma Cell Line Growth Inhibition: An in-Vitro Study
Melanoma, one of the most lethal cancers, originates from epidermal layer. An advanced type of malignant melanoma represents a poor response to chemotherapy or other medications due to intrinsic and/or acquired resistance to antineoplastic drugs. Taraxasterol is a pentacyclic-triterpene agent mainly extracted from Dandelion herb with anti-proliferative and apoptotic features on cancer cells. Thus, this paper investigated the apoptosis pathway caused by Taraxasterol in the human melanoma cell line (hMCL).
hMCLs were treated with Taraxasterol and IC50 index was calculated using MTT assay. Then, apoptosis rate was evaluated by DNA Fragmentation Calorimetric technique. Finally, apoptosis pathway was investigated through various molecular laboratory assays.
Low cellular viability level was found as concentration and time-dependent routes. Induction of apoptosis by IC50 value of Taraxasterol was found significantly (p<0.05) effective. Mitochondria membrane potential index was reduced by Taraxasterol significantly (p<0.05). Also, the cytosolic levels of cytochrome C and expression level of caspase 3, 8, and 9 genes in hMCL were increased significantly (p<0.05) following Taraxasterol administration.
Taraxasterol represents anti-proliferative and toxic effects against hMCL by induction of apoptosis.
Apoptosis , Taraxasterol , Melanoma , Cell Line , In Vitro
-
Hydroalcoholic Extract of <i>Fumaria Parviflora</i> L. Can Potentially Detoxificate HepG2 Cell Line Following Carbon Tetrachloride Exposure
Amir Abdolmaleki, Mohsen Zhaleh, Ali Ghanbari, Iraj Rashidi, , Fateme Feizi, Fuzieh Khani Hematabadi
Journal of Clinical Research in Paramedical Sciences, Dec 2024 -
Oral administration of crocin-loaded solid lipid nanoparticles inhibits neuroinflammation in a rat model of epileptic seizures by activating SIRT1 expression
Seyran Kakebaraei, Mohammadreza Gholami, Touraj Zamir Nasta, Elham Arkan, Fariborz Bahrehmand, Sajad Fakhri, *
Research in Pharmaceutical Sciences, Aug 2024